EUVIMEDEUVIMED entdecken
Crossref

Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells – A PROSPAX study

Ceren Tunca iD, Eylül Ece İşlek Camadan, Natalia Smolina, Robin J Palvadeau iD, Özgür Öztop Çakmak iD, Atay Vural, Andreas Traschütz iD, Filippo M Santorelli, Bernard Brais, Rebecca Schüle iD, Matthis Synofzik iD, A Nazlı Başak iD

Movement Disorders · 2024

DOI: 10.1002/mds.30012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2024. Verfasst von Ceren Tunca und 11 weiteren Autor:innen. Beteiligte Einrichtung: Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Heat-Shock Proteins, Muscle Spasticity, Spinocerebellar Ataxias. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Ministero della Salute, Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal recessive spastic ataxia of Charlevoix‐Saguenay (ARSACS) is a common recessive ataxia that is still underdiagnosed worldwide. An easily accessible diagnostic biomarker might help to diagnostically confirm patients presenting SACS variants of unknown significance (VUS) or atypical phenotypes.

Objectives

To detect sacsin in peripheral blood mononuclear cells (PBMCs) and to validate its diagnostic biomarker quality to discriminate biallelic SACS patients (including patients with VUS and/or atypical phenotypes) against healthy controls, non‐ARSACS spastic ataxia patients, and heterozygous SACS carriers.

Methods

Sacsin protein levels in PBMCs were assessed in patients versus controls and validated in skin‐derived fibroblasts.

Results

Patients with biallelic SACS variants – including patients with VUS and/or atypical phenotypes – showed loss of sacsin in PBMCs, with discriminative performance against healthy, heterozygous, and non‐ARSACS controls. This included all investigated SACS missense variants. Also, C‐terminal variants escaping nonsense‐mediated decay, while not differing from controls in expression level, showed lower molecular weight in this assay.

Conclusions

Assessing sacsin levels using PBMCs offers an easy, peripherally accessible diagnostic biomarker for ARSACS, with PBMCs being much less invasive and easier to handle than fibroblasts. Additionally, this might be a potential target‐engagement blood biomarker for sacsin‐increasing therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocytes, MononuclearHeat-Shock ProteinsMuscle SpasticitySpinocerebellar AtaxiasHumansMaleFemaleAdultBiomarkersHeterozygoteFibroblasts

Stichwörter der Autor:innen

ARSACSPBMCdiagnostic assayfibroblasts

Substanzen

SACS protein, humanHeat-Shock ProteinsBiomarkers

Autor:innen und Institutionen

  • Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.
  • Department of Neurology, School of Medicine, Koç University, İstanbul, Turkey.
  • Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Tübingen, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
  • Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Ceren Tunca, Robin J Palvadeau, Özgür Öztop Çakmak, Andreas Traschütz, Rebecca Schüle, Matthis Synofzik, A Nazlı Başak

Förderung

  • Ministero della Salute
  • Bundesministerium für Bildung und Forschung
  • Deutsche Forschungsgemeinschaft
  • Else Kröner-Fresenius-Stiftung
  • Universitätsklinikum Tübingen
  • Suna ve İnan Kıraç Vakfı

Zitieren

APA

Tunca, C., İşlek Camadan, E. E., Smolina, N., Palvadeau, R. J., Öztop Çakmak, Ö., Vural, A., Traschütz, A., Santorelli, F. M., Brais, B., Schüle, R., Synofzik, M., & Başak, A. N. (2024). Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells – A PROSPAX study. Movement Disorders. https://doi.org/10.1002/mds.30012

Vancouver

Tunca C, İşlek Camadan EE, Smolina N, Palvadeau RJ, Öztop Çakmak Ö, Vural A, et al. Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells – A PROSPAX study. Movement Disorders. 2024. doi:10.1002/mds.30012

BibTeX
@article{Tunca2024,
  author = {Tunca, Ceren and İşlek Camadan, Eylül Ece and Smolina, Natalia and Palvadeau, Robin J and Öztop Çakmak, Özgür and Vural, Atay and Traschütz, Andreas and Santorelli, Filippo M and Brais, Bernard and Schüle, Rebecca and Synofzik, Matthis and Başak, A Nazlı},
  title = {Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells – A PROSPAX study},
  journal = {Movement Disorders},
  year = {2024},
  doi = {10.1002/mds.30012}
}
Kostenlos starten →